Priority Date: 24.03.14 (US 201461969483P)
MRNA THERAPY FOR TREATMENT OF OCULAR DISEASES
- Application ID: EP18201321
- Status: █ Examination is in progress
Attorney
operating since 1848
Headquarter in London
and
2 offices
active in Legal Services and IP Consulting
Specialization
This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Carpmaels & Ransford LLP is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 173 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.
Timeline
- 24.03.2014 - Priority Date (US 201461969483P)
- 06.03.2019 - Publication A1 (EP3450553)